257 related articles for article (PubMed ID: 28705916)
21. Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[
Yang Q; Zhu W; Ren C; Ji H; Wang D; Liu Y; Li F; Du Y; Liu Y; Huo L
Nucl Med Biol; 2021; 94-95():32-37. PubMed ID: 33486437
[TBL] [Abstract][Full Text] [Related]
22. Preliminary results of biodistribution and dosimetric analysis of [
Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
Ann Nucl Med; 2019 Jun; 33(6):404-413. PubMed ID: 30877560
[TBL] [Abstract][Full Text] [Related]
23. 18 F-MFBG PET/CT Is an Effective Alternative of 68 Ga-DOTATATE PET/CT in the Evaluation of Metastatic Pheochromocytoma and Paraganglioma.
Wang P; Li T; Cui Y; Zhuang H; Li F; Tong A; Jing H
Clin Nucl Med; 2023 Jan; 48(1):43-48. PubMed ID: 36252940
[TBL] [Abstract][Full Text] [Related]
24.
Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
[TBL] [Abstract][Full Text] [Related]
25. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
Challapalli A; Sharma R; Hallett WA; Kozlowski K; Carroll L; Brickute D; Twyman F; Al-Nahhas A; Aboagye EO
J Nucl Med; 2014 Feb; 55(2):256-63. PubMed ID: 24492392
[TBL] [Abstract][Full Text] [Related]
26. Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging.
Zhang-Yin J; Dirand AS; Sasanelli M; Corrégé G; Peudon A; Kiffel T; Nataf V; Clerc J; Montravers F; Talbot JN
J Nucl Med; 2017 Aug; 58(8):1230-1235. PubMed ID: 28209907
[No Abstract] [Full Text] [Related]
27. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.
Krebs S; Veach DR; Carter LM; Grkovski M; Fornier M; Mauro MJ; Voss MH; Danila DC; Burnazi E; Null M; Staton K; Pressl C; Beattie BJ; Zanzonico P; Weber WA; Lyashchenko SK; Lewis JS; Larson SM; Dunphy MPS
J Nucl Med; 2020 Nov; 61(11):1580-1587. PubMed ID: 32169913
[TBL] [Abstract][Full Text] [Related]
28. Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe,
Ma X; Wang S; Wang S; Liu D; Zhao X; Chen H; Kang F; Yang W; Wang J; Cheng Z
J Nucl Med; 2019 Jan; 60(1):16-22. PubMed ID: 29853651
[No Abstract] [Full Text] [Related]
29. Combined model-based and patient-specific dosimetry for
Plyku D; Mena E; Rowe SP; Lodge MA; Szabo Z; Cho SY; Pomper MG; Sgouros G; Hobbs RF
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):989-998. PubMed ID: 29460025
[TBL] [Abstract][Full Text] [Related]
30.
Zhang Y; Kupferschlaeger J; Lang P; Reischl G; Handgretinger RJ; Fougère C; Dittmann H
J Nucl Med; 2022 Feb; 63(2):205-211. PubMed ID: 34049985
[TBL] [Abstract][Full Text] [Related]
31. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
32. 68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors.
Pettinato C; Sarnelli A; Di Donna M; Civollani S; Nanni C; Montini G; Di Pierro D; Ferrari M; Marengo M; Bergamini C
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):72-9. PubMed ID: 17874094
[TBL] [Abstract][Full Text] [Related]
33. A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of
Zhu W; Cheng Y; Jia R; Zhao H; Bai C; Xu J; Yao S; Huo L
J Nucl Med; 2021 Oct; 62(10):1398-1405. PubMed ID: 33579804
[No Abstract] [Full Text] [Related]
34. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.
Challapalli A; Kenny LM; Hallett WA; Kozlowski K; Tomasi G; Gudi M; Al-Nahhas A; Coombes RC; Aboagye EO
J Nucl Med; 2013 Sep; 54(9):1551-6. PubMed ID: 23949910
[TBL] [Abstract][Full Text] [Related]
35. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
[TBL] [Abstract][Full Text] [Related]
36. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
Matthay KK; Weiss B; Villablanca JG; Maris JM; Yanik GA; Dubois SG; Stubbs J; Groshen S; Tsao-Wei D; Hawkins R; Jackson H; Goodarzian F; Daldrup-Link H; Panigrahy A; Towbin A; Shimada H; Barrett J; Lafrance N; Babich J
J Nucl Med; 2012 Jul; 53(7):1155-63. PubMed ID: 22700000
[TBL] [Abstract][Full Text] [Related]
37. Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteers.
Doss M; Kolb HC; Walsh JC; Mocharla VP; Zhu Z; Haka M; Alpaugh RK; Chen DY; Yu JQ
Mol Imaging Biol; 2014 Oct; 16(5):739-46. PubMed ID: 24696183
[TBL] [Abstract][Full Text] [Related]
38. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
Lee CL; Wahnishe H; Sayre GA; Cho HM; Kim HJ; Hernandez-Pampaloni M; Hawkins RA; Dannoon SF; VanBrocklin HF; Itsara M; Weiss WA; Yang X; Haas-Kogan DA; Matthay KK; Seo Y
Med Phys; 2010 Sep; 37(9):4861-7. PubMed ID: 20964203
[TBL] [Abstract][Full Text] [Related]
39. Clinical Application of 18F-AlF-NOTA-Octreotide PET/CT in Combination With 18F-FDG PET/CT for Imaging Neuroendocrine Neoplasms.
Long T; Yang N; Zhou M; Chen D; Li Y; Li J; Tang Y; Liu Z; Li Z; Hu S
Clin Nucl Med; 2019 Jun; 44(6):452-458. PubMed ID: 30985413
[TBL] [Abstract][Full Text] [Related]
40. The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.
Piccardo A; Treglia G; Fiz F; Bar-Sever Z; Bottoni G; Biassoni L; Borgwardt L; de Keizer B; Jehanno N; Lopci E; Kurch L; Massollo M; Nadel H; Roca Bielsa I; Shulkin B; Vali R; De Palma D; Cecchin D; Santos AI; Zucchetta P
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):756-767. PubMed ID: 37962616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
